A partnership roundup covers deals from IntraGel Therapeutics/UroGen Pharma and Lupin/Tenpoint Therapeutics, FDA approves ...
UroGen Pharma has invested in IntraGel Therapeutics and secured an exclusive option to license Tumocure, and Lupin's ...
FDA approval in adult FOP targets disease-driving Activin A biology, addressing progressive heterotopic ossification that ...
Pharmaceutical reshoring is constrained by supplier qualification, process validation, FDA compliance readiness, workforce ...
In pharma's AI transformation, the technology was never the hard part — fixing the operating model that has to act on what AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results